Xeomin® and Gait Related Mobility After Stroke

Summary

The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).

Timeline

Start

2021-10-19

Primary completion

2027-04

Completion

2027-04

Drugs

Indications